shRNA-mediated gene-silencing technology combined with cell-based practical readouts reveals potential targets directly, providing an opportunity to identify drugs against the target without understanding the exact role of the target in the pathophysiological processes of interest. loss of life receptor (DR)-mediated apoptosis. Network-based modeling was utilized to anticipate small-molecule inhibitors for many applicant apoptosis mediators, including… Continue reading shRNA-mediated gene-silencing technology combined with cell-based practical readouts reveals potential targets